Skip to main content Help with accessibility Skip to main navigation

February 2021 updates to the website

The website has now been updated following February's LSCMMG

The following guidelines have been added/updated:

Rheumatoid Arthritis High Cost Drugs Pathway - Update

The following Items will be updated and added to the website following the Joint Committee of CCGs (JCCCG) Meeting:

Brolucizumab - For treating wet age-related macular degeneration (TA672)